Predicate |
Object |
contentType |
Journal Article|Research Support, Non-U.S. Gov't|Review |
endingPage |
421 |
issn |
1387-2877 1875-8908 |
issueIdentifier |
2 |
pageRange |
405-421 |
publicationName |
Journal of Alzheimer's disease : JAD |
startingPage |
405 |
bibliographicCitation |
von Bernhardi R. Immunotherapy in Alzheimer's disease: where do we stand? Where should we go? J Alzheimers Dis. 2010;19(2):405–21. doi: 10.3233/jad-2010-1248. PMID: 20110590. |
creator |
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4960fa9cfc0a943241fac6f59783ab3 |
date |
2010-01-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
identifier |
https://pubmed.ncbi.nlm.nih.gov/20110590 https://doi.org/10.3233/jad-2010-1248 |
isPartOf |
https://portal.issn.org/resource/ISSN/1875-8908 https://portal.issn.org/resource/ISSN/1387-2877 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/21942 |
language |
English |
source |
https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/ |
title |
Immunotherapy in Alzheimer's Disease: Where Do We Stand? Where Should We Go? |
discussesAsDerivedByTextMining |
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6852 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7568 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10395 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID2675 |